Current Ratio of Adaptimmune Therapeutics PLC from 30 Sep 2016 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Adaptimmune Therapeutics PLC quarterly Current Ratio in % history and change rate from 30 Sep 2016 to 30 Jun 2025.
  • Adaptimmune Therapeutics PLC Current Ratio for the quarter ending 30 Jun 2025 was 266%, a 9.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Adaptimmune Therapeutics PLC Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2025 266% -27% -9.1% 30 Jun 2025
Q1 2025 302% +0.77% +0.26% 31 Mar 2025
Q4 2024 316% +2.1% +0.67% 31 Dec 2024
Q3 2024 313% -27% -7.8% 30 Sep 2024
Q2 2024 293% -75% -20% 30 Jun 2024
Q1 2024 301% -92% -23% 31 Mar 2024
Q4 2023 314% -130% -29% 31 Dec 2023
Q3 2023 340% -167% -33% 30 Sep 2023
Q2 2023 368% -206% -36% 30 Jun 2023
Q1 2023 394% -275% -41% 31 Mar 2023
Q4 2022 444% -357% -45% 31 Dec 2022
Q3 2022 507% -406% -44% 30 Sep 2022
Q2 2022 574% -464% -45% 30 Jun 2022
Q1 2022 669% -473% -41% 31 Mar 2022
Q4 2021 801% -261% -25% 31 Dec 2021
Q3 2021 912% +16% +1.8% 30 Sep 2021
Q2 2021 1037% +357% +52% 30 Jun 2021
Q1 2021 1142% +626% +121% 31 Mar 2021
Q4 2020 1061% +541% +104% 31 Dec 2020
Q3 2020 896% +233% +35% 30 Sep 2020
Q2 2020 680% -141% -17% 30 Jun 2020
Q1 2020 516% -197% -28% 31 Mar 2020
Q4 2019 521% -53% -9.2% 31 Dec 2019
Q3 2019 663% +235% +55% 30 Sep 2019
Q2 2019 821% +466% +131% 30 Jun 2019
Q1 2019 714% +306% +75% 31 Mar 2019
Q4 2018 573% +113% +24% 31 Dec 2018
Q3 2018 429% -105% -20% 30 Sep 2018
Q2 2018 355% -332% -48% 30 Jun 2018
Q1 2018 408% -322% -44% 31 Mar 2018
Q4 2017 461% -370% -45% 31 Dec 2017
Q3 2017 534% -481% -47% 30 Sep 2017
Q2 2017 687% 30 Jun 2017
Q1 2017 730% 31 Mar 2017
Q4 2016 831% 31 Dec 2016
Q3 2016 1016% 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.